Thrombotic thrombocytopenic purpura diagnostic study of choice: Difference between revisions
Line 20: | Line 20: | ||
{{#Widget:PLASMIC score}} | {{#Widget:PLASMIC score}} | ||
<br> | <br> | ||
'''<big>Risk of ADAMPTS13 deficiency</big>''' '''<big>in adults with suspected TTP</big>''' '''<big>:</big>''' | '''<big>Risk of ADAMPTS13 deficiency</big>''' '''<big>in adults with suspected TTP</big>''' <ref name="JammeRondeau2017">{{cite journal|last1=Jamme|first1=Matthieu|last2=Rondeau|first2=Eric|title=The PLASMIC score for thrombotic thrombocytopenic purpura|journal=The Lancet Haematology|volume=4|issue=4|year=2017|pages=e148–e149|issn=23523026|doi=10.1016/S2352-3026(17)30024-8}}</ref>'''<big>:</big>''' | ||
* '''Low-risk''' = 0 to 4 points | * '''Low-risk''' = 0 to 4 points | ||
* '''Intermediate risk''' = 5 points | * '''Intermediate risk''' = 5 points |
Revision as of 22:14, 24 August 2018
Thrombotic thrombocytopenic purpura Microchapters |
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura diagnostic study of choice |
FDA on Thrombotic thrombocytopenic purpura diagnostic study of choice |
CDC on Thrombotic thrombocytopenic purpura diagnostic study of choice |
Thrombotic thrombocytopenic purpura diagnostic study of choice in the news |
Blogs on Thrombotic thrombocytopenic purpura diagnostic study of choice |
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Study of choice
- ADAMTS13 test:
Studies that may be considered for diagnosis of the suspected cases of TTP:
- Complete blood count (CBC) with platelet count
- Review of the peripheral blood smear
- Serum electrolytes and creatinine
- Serum lactate dehydrogenase (LDH)
- Serum bilirubin level
- Coagulation testing ( PT, aPTT, fibrinogen, D-dimer)
- Serum haptoglobin level
- Direct antiglobulin (Coombs) test (DAT)
- ADAMTS13 activity and inhibitor testing
- Stool exam
PLASMIC score
Risk of ADAMPTS13 deficiency in adults with suspected TTP [1]:
- Low-risk = 0 to 4 points
- Intermediate risk = 5 points
- High-risk = 6 to 7 points
References
- ↑ Jamme, Matthieu; Rondeau, Eric (2017). "The PLASMIC score for thrombotic thrombocytopenic purpura". The Lancet Haematology. 4 (4): e148–e149. doi:10.1016/S2352-3026(17)30024-8. ISSN 2352-3026.